Expression vector of human E2F4.
Alternative name | SET-0113_9-1 |
---|---|
Clone info. | Expression vector of human E2F4. Expression has not yet been confirmed. |
Comment | PCR cloning, forward primer: gcggaggccgggccacaggc; reverse primer: tcagaggttgagaacaggcacatc. |
Vector backbone | pCMV_S-FLAG (RDB05956) (Plasmid) |
Size of vector backbone | 5.5 kb |
Selectable markers | Amp^r (E. coli), Neo^r (mammalian cell) |
Growth conditions | 37C, LB+Amp |
Gene/insert name | Human E2F transcription factor 4,p107/p103-binding cDNA |
Depositor|Developer | DNA Bank, | |
Please check terms and conditions set forth by the depositor, which are specified in the RIKEN BRC Catalog and/or Web Catalog.
Ordering forms | Order form [Credit Card Payment ![]() ![]() ![]() MTA, for use for not-for-profit academic purpose [Word ![]() ![]() MTA, for use for for-profit purpose [Word ![]() Please visit Information of Request for Distribution.[link] |
---|---|
Terms and conditions for distribution | The RECIPIENT agrees to describe RIKEN BRC as the source of the MATERIAL in any publication. Additional terms and conditions: Regrding pRc/CMV: a) The modified pRc/CMV, and their descendants (collectively, LIFE MATERIALS), should be used for pre-clinical/non-human, research use only. b) LIFE MATERIALS shall not be used for any commercial purposes. c) LIFE MATERIALS shall not be transferred beyond the specified recipient. d) Recipient must contact Thermo Fisher Scientific Inc. at outlicense@thermofisher.com for any desired use of LIFE MATERIALS beyond the scope of a) to c) above. |
必要書類 | 提供依頼書 ![]() ![]() 提供同意書 (MTA, 非営利学術目的用)[Word ![]() ![]() 提供同意書 (MTA, 営利目的用)[Word ![]() 手続きの概要は、「提供申込みについて[link]」をご覧ください。 |
---|---|
MTAに書く使用条件 | 発表に際し、理研BRCから入手したことを明記すること。 付加的使用条件: pRc/CMVについて: a) The modified pRc/CMV, and their descendants (collectively, LIFE MATERIALS), should be used for pre-clinical/non-human, research use only. b) LIFE MATERIALS shall not be used for any commercial purposes. c) LIFE MATERIALS shall not be transferred beyond the specified recipient. d) Recipient must contact Thermo Fisher Scientific Inc. at outlicense@thermofisher.com for any desired use of LIFE MATERIALS beyond the scope of a) to c) above. |
Catalog # | Resource name | Shipping form | Fee |
---|---|---|---|
RDB06786 | pCMFlag_hsE2F4 | DNA solution |
JPY 9,460 (not-for-profit academic purpose) JPY 18,920 (for-profit-research purpose) plus cost of shipping containers, dry ice (if required) and shipping charge |
Materials & Methods section:
The pCMFlag_hsE2F4 was provided by the RIKEN BRC through the National BioResource Project of the MEXT, Japan (cat. RDB06786). |
Reference section:
Further references such as user reports and related articles (go to bottom)
RIKEN BRC has sequenced portions of this material for quality test.
Please review the QC test results indicated by icon as well as clone information before placing your order.
Test sheet | RDB12837_A4Hb.pdf ![]() |
---|
Nucleotide sequence of a portion of this resource (if available).
Primer: CMV-Forward Sequence file: RDB12837_A4Hba.seq ![]() |
---|
>06786_12837_A4Hb_CMV-Foward_C07_07.ab1 1 CGTTCCTCCG CCCATTGACG CAATGGGCGG TAGGCGTGTA CGGTGGGAGG TCTATATAAG 61 CAGAGCTCTC TGGCTAACTA GAGAACCCAC TGCTTACTGG CTTATCGAAA TTAATACGAC 121 TCACTATAGG GAGACCCAAG CTGAATTCAC CATGGACTAC AAGGACGATG ACGATAAGGC 181 GGCCGCGGAG GCCGGGCCAC AGGCGCCGCC GCCCCCGGGC ACTCCAAGCC GGCACGAAAA 241 GAGCCTGGGA CTGCTCACCA CCAAGTTCGT GTCCCTTCTG CAGGAGGCCA AGGACGGCGT 301 GCTTGACCTC AAGCTGGCAG CTGACACCCT AGCTGTACGC CAGAAGCGGC GGATTTACGA 361 CATTACCAAT GTTTTGGAAG GTATCGGGCT AATCGAGAAA AAGTCCAAGA ACAGCATCCA 421 GTGGAAGGGT GTGGGGCCTG GCTGCAATAC CCGGGAGATT GCTGACAAAC TGATTGAGCT 481 CAAGGCAGAG ATCGAGGAGC TGCAGCAGCG GGAGCAAGAA CTAGACCAGC ACAAGGTGTG 541 GGTGCAGCAG AGCATCCGGA ACGTCACAGA GGACGTGCAG AACAGCTGTT TGGCCTACGT 601 CACTCATGAG GACATCTGCA GATGCTTTGC TGGAGATACC CTCTTGGCCA TCCGGGCCCC 661 ATCAGGCACC AGCCTGGAGG TGCCCATCCC AGAGGGTCTC AATGGGCAGA AGAAGTACCA 721 GATTCACCTG AAGAGTGTGA GTGGTCCCAT TGAGGTTCTG CTGGTGAACA AGGAGGCATG 781 GAGCTCACCC CCTGTGGCTG TGCCTGTGCC ACCACCTGAA GATTTGCTCC AGAGCCCATC 841 TGCTGTTTCT ACACCTCCAC CTCTGCCCAA GCCTGCCCTA GCCCAGTCCC AGGAAGCCTC 901 ACGTCCAAAT AGTCCTCAGC TCACTCCCAC TGCTGTCCCT GGCAGTGCAG AAGTCCAGGG 961 AATGGCTGGG CCCAGCAGCT GAGATCACAG TGAGTGGCGG GCCCTGGGAC TGATAGCAAA 1021 GGGACAGTGG TGAGCTCAGT TCACTCCCCA CTGGGCCCCA ACACACTGGA CACCCGGGCA 1081 CTGCAGTCTT CTGCCTTGCT TGGACAGCCA GCCAGCCAGG CAGCAAGGCA GGCCAGGCCA 1141 GG // |
Primer: BGH_rev Sequence file: RDB12837_A4Hbb.seq ![]() |
>06786_12837_A4Hb_BGHrev_D07_10.ab1 1 GCCTTACCCA TTAGGGTGAA CTATAGAATA GGGCCCTCTA GATGCATGCT CGAGCGGCTC 61 AGAGGTTGAG AACAGGCACA TCAAAGAGGT CACAGACACC TTCACTCTCG TCCAGGTTGT 121 AGATATAATC GTGGTCTCCC GGGGGTGGAG AAAGACGAAG CAGAGGGGCA AACACTTCTG 181 AGGACATCAA CTCCTCCAGC AGCTCCGAGC TCATGCACTC TCGTGTGGGA TCAAAGATTT 241 CTGACAGCTC TTTGGGGAGT TCCAAAACAC CTGTGGGGTC TGCCTTGATG GGCTCAAAGG 301 AGGTAGAAGG GTTGGGTCCG GACGAACTGC TGCTGTTACT GTTGCTGCTG CTGCTGCTGC 361 TGCTGCTGCT GCTGCTGCTG CTGTCCAGCA GGGCAGAAGA CTGCAGTGGC CGGGTGTCCA 421 GTGTTGTTGG GCCCAGTGGG AGTGAACTGA GCTCACCACT GTCCTTGCTA TCAGTCCCAG 481 GGCCGCCACT CACTGTGATC TCAGCTGCTG GGCCAGCCAT TCCCTGGACT TCTGCACTGC 541 CAGGGACAGC AGTGGGAGTG AGCTGAGGAC TATTTGGACG TGAGGCTTCC TGGGACTGGG 601 CTAGGGCAGG CTTGGGCAGA GGTGGAGGTG TAGAAACAGC AGATGGGCTC TGGAGCAAAT 661 CTTCAGGTGG TGGCACAGGC ACAGCCACAG GGGGTGAGCT CCATGCCTCC TTGTTCACCA 721 GCAGAACCTC AATGGGACCA CTCACACTCT TCAGGTGAAT CTGGTACTTC TTCTGCCCAT 781 TGAGACCCTC TGGGATGGGC ACCTCCAGGC TGGTGCCTGA TGGGGCCCGG ATGGCCAAGA 841 GGGTATCTCC AGCAAAGCAT CTGCAGATGT CCTCATGAGT GACGTAGGCC AAACAGCTGT 901 TCTGCACGTC CTCTGTGACG TTCCGGATGC TCTGCTGCAC CCACACCTTG TGCTGGTCTA 961 GTTCTTGCTC CCGCTGCTGC AGCTCCTCGA TCTCTGCCTT GAGCTCAATC AGTTGTCAGC 1021 AAATCTCCCG GGTATTGCAG CCCAGGGCCC CACACCCTTT CACTGGAATG CTGGTTCTTG 1081 GACTTTTTTC TCGATTAGCC CGGATTACCC TCCAAACATG GTTAATGTTC GTAAATCCCG 1141 TCCGCGCTTC CTTGC // |
Please visit Sequencing and PCR primers for primer information.
Original, user report and related articles
Featured content